Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Liquidia Corporation

LQDANASDAQ
Healthcare
Biotechnology
$35.05
$1.46(4.35%)
U.S. Market opens in 14h 28m

Liquidia Corporation (LQDA) Stock Overview

Explore Liquidia Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.8B
P/E Ratio-23.19
EPS (TTM)$-1.46
ROE-2.97%
Fundamental Analysis

AI Price Forecasts

1 Month$42.14
3 Months$46.56
1 Year Target$46.71

LQDA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Liquidia Corporation (LQDA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.32, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $46.71.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -23.19 and a market capitalization of 2.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.53%
5-Day Change
-5.13%
1-Month Change
-19.34%
3-Month Change
12.47%
6-Month Change
21.98%
Year-to-Date (YTD) Change
4.27%
1-Year Change
106.04%
3-Year Change
329.10%
5-Year Change
946.006%
All-Time (Max) Change
194.95%

Contact Information

919 328 4400
419 Davis Drive, Morrisville, NC, 27560

Company Facts

1,700 Employees
IPO DateJul 26, 2018
CountryUS
Actively Trading

Frequently Asked Questions